← FDA Drug Approvals (Drugs@FDA)

BARHEMSYS

NDA · New Drug Application · Sponsor: ACACIA · Approved 2020-02-26

Drug application

FDA Application #

NDA209510

Application type

New Drug Application

Brand name

BARHEMSYS

Generic name

AMISULPRIDE

Active ingredients

AMISULPRIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACACIA

Manufacturer

Acacia Pharma Ltd

First approval

2020-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown